Kaiser Permanente
FDA Advisory Committee Supports Safety and Effectiveness of Paxlovid for COVID-19
Available data support the safety and effectiveness of Paxlovid to treat mild to moderate COVID-19 in adults who ...
MARCH 17, 2023
Bucking Trend, Kaiser Boosts Biosimilar Uptake
Adoption of infliximab biosimilars has been negligible across the United States, but Kaiser Permanente Northwest ...
FEBRUARY 14, 2019
Patients Report Worse Outcomes With Higher Opioid Doses
Concerns with the safety and adverse effects of opioids have grown with increases in prescribing and dose, and ...
APRIL 11, 2017
National Mortality Rates due to Heart Disease, Stroke Leveling Off
Until 2011, total cardiovascular mortality was declining an average of 3.8% annually. Now, the decline is less ...
JUNE 29, 2016
Load more